Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Barrett-Lee

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Endocrine-Related Cancer|August 23, 2005
Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: a review of chemotherapyP J Barrett-Lee
British Journal of Cancer|January 19, 2000
Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapyP J Barrett-Lee, N P Bailey, M E O'Brien, et al.
Cancer Research|December 15, 1987
Characterization of estrogen receptor messenger RNA in human breast cancerP J Barrett-Lee, M T Travers, R A McClelland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Docetaxel in the community setting: an analysis of 377 breast cancer patients treated with docetaxel (Taxotere) in the UK. UK Study GroupM E O'Brien, R C Leonard, P J Barrett-Lee, et al.
European Journal of Cancer Care|February 7, 2002
Improvement in quality of life for cancer patients treated with epoetin alfaS E Libretto, P J Barrett-Lee, K Branson, et al.
British Medical Journal (Clinical Research Ed.)|June 11, 1988
Growth factor expression in normal, benign, and malignant breast tissueM T Travers, P J Barrett-Lee, U Berger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac riskP J Barrett-Lee, J M Dixon, C Farrell, et al.
British Journal of Cancer|March 5, 2009
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoringA L Jones, M Barlow, P J Barrett-Lee, et al.
Breast Cancer Research and Treatment|March 12, 2011
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancerR Coleman, E Woodward, J Brown, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Endocrine-Related Cancer|August 23, 2005
Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: a review of chemotherapyP J Barrett-Lee
British Journal of Cancer|January 19, 2000
Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapyP J Barrett-Lee, N P Bailey, M E O'Brien, et al.
Cancer Research|December 15, 1987
Characterization of estrogen receptor messenger RNA in human breast cancerP J Barrett-Lee, M T Travers, R A McClelland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Docetaxel in the community setting: an analysis of 377 breast cancer patients treated with docetaxel (Taxotere) in the UK. UK Study GroupM E O'Brien, R C Leonard, P J Barrett-Lee, et al.
European Journal of Cancer Care|February 7, 2002
Improvement in quality of life for cancer patients treated with epoetin alfaS E Libretto, P J Barrett-Lee, K Branson, et al.
British Medical Journal (Clinical Research Ed.)|June 11, 1988
Growth factor expression in normal, benign, and malignant breast tissueM T Travers, P J Barrett-Lee, U Berger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac riskP J Barrett-Lee, J M Dixon, C Farrell, et al.
British Journal of Cancer|March 5, 2009
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoringA L Jones, M Barlow, P J Barrett-Lee, et al.
Breast Cancer Research and Treatment|March 12, 2011
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancerR Coleman, E Woodward, J Brown, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Pageof 2